Torchilin VP - Search Results

1

Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.

Elbayoumi TA, Torchilin VP. Elbayoumi TA, et al. Among authors: torchilin vp. Mol Pharm. 2009 Jan-Feb;6(1):246-54. doi: 10.1021/mp8001528. Mol Pharm. 2009. PMID: 19049322 Free PMC article.

2

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.

Lukyanov AN, Elbayoumi TA, Chakilam AR, Torchilin VP. Lukyanov AN, et al. Among authors: torchilin vp. J Control Release. 2004 Nov 5;100(1):135-44. doi: 10.1016/j.jconrel.2004.08.007. J Control Release. 2004. PMID: 15491817

3

Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.

Elbayoumi TA, Torchilin VP. Elbayoumi TA, et al. Among authors: torchilin vp. Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1196-205. doi: 10.1007/s00259-006-0139-x. Epub 2006 Jun 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16763815

4

Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents.

Elbayoumi TA, Pabba S, Roby A, Torchilin VP. Elbayoumi TA, et al. Among authors: torchilin vp. J Liposome Res. 2007;17(1):1-14. doi: 10.1080/08982100601186474. J Liposome Res. 2007. PMID: 17454399

5

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.

Elbayoumi TA, Torchilin VP. Elbayoumi TA, et al. Among authors: torchilin vp. Eur J Pharm Sci. 2007 Nov;32(3):159-68. doi: 10.1016/j.ejps.2007.05.113. Epub 2007 Jun 7. Eur J Pharm Sci. 2007. PMID: 17707615 Free PMC article.

6

Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice.

Elbayoumi TA, Torchilin VP. Elbayoumi TA, et al. Among authors: torchilin vp. Int J Pharm. 2008 Jun 5;357(1-2):272-9. doi: 10.1016/j.ijpharm.2008.01.041. Epub 2008 Feb 2. Int J Pharm. 2008. PMID: 18329201 Free PMC article.

7

Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.

ElBayoumi TA, Torchilin VP. ElBayoumi TA, et al. Among authors: torchilin vp. Clin Cancer Res. 2009 Mar 15;15(6):1973-80. doi: 10.1158/1078-0432.CCR-08-2392. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276264 Free PMC article.

8

Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.

Mu L, Elbayoumi TA, Torchilin VP. Mu L, et al. Among authors: torchilin vp. Int J Pharm. 2005 Dec 8;306(1-2):142-9. doi: 10.1016/j.ijpharm.2005.08.026. Epub 2005 Oct 19. Int J Pharm. 2005. PMID: 16242875 Free PMC article.

9

Liposomes for targeted delivery of antithrombotic drugs.

Elbayoumi TA, Torchilin VP. Elbayoumi TA, et al. Among authors: torchilin vp. Expert Opin Drug Deliv. 2008 Nov;5(11):1185-98. doi: 10.1517/17425240802497457. Expert Opin Drug Deliv. 2008. PMID: 18976130 Review.

10

Current trends in liposome research.

Elbayoumi TA, Torchilin VP. Elbayoumi TA, et al. Among authors: torchilin vp. Methods Mol Biol. 2010;605:1-27. doi: 10.1007/978-1-60327-360-2_1. Methods Mol Biol. 2010. PMID: 20072870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters